POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.

Congressional Hearing on COVID-19 Variants and Research Needs

Original title: COVID-19 VARIANTS AND EVOLVING RESEARCH NEEDS

Record date · January 1, 2022

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

The House held a virtual hearing on May 12, 2021, to discuss the evolution of COVID-19 variants and the ongoing research required to address them. Experts and lawmakers examined the risks of new variants, including potential vaccine resistance and increased transmissibility.

Why it matters

This hearing established the federal legislative record on the scientific challenges posed by COVID-19 mutations, which informs future public health funding and national pandemic response strategies.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

General Public

The research discussed impacts national public health strategies and vaccine efficacy monitoring.

Directly affected

Scientific Research Community

The hearing identifies priorities for federal research funding and focus areas for viral surveillance.

Key Facts

  • The hearing took place on May 12, 2021, via Zoom.
  • The Subcommittee on Investigations and Oversight held the hearing to discuss COVID-19 variants and evolving research needs.
  • As of May 2021, nearly 60 percent of Americans had received at least one COVID-19 vaccination dose.
  • The hearing addressed the risk of 'escape variants' that could potentially resist vaccine-induced immunity.
Show all 7 facts
  • The Subcommittee operated under House Resolution 8, which authorized virtual proceedings.
  • Witnesses included experts from CAPRISA, Yale (epidemiology), Argonne National Laboratory, and Johns Hopkins Center for Health Security.
  • The hearing included an appendix containing post-hearing questions answered by Dr. Stephen Streiffer.

Frequently Asked Questions

What was the purpose of this hearing?
The hearing was held to gather expert testimony on how COVID-19 variants evolve and what research is needed to monitor and combat them.
Who participated in the hearing?
The hearing was conducted by the House , featuring testimony from four scientific experts in epidemiology and laboratory research.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

temporal pattern100% confidence

Pandemic-era Virtual Governance

The document highlights the reliance on House Resolution 8 to conduct official federal business via Zoom during the 2021 pandemic period.

Connected Entities

Eddie Bernice Johnson, Bill Foster, Caitlin Rivers and 4 more
PersonEddie Bernice Johnson“Chairwoman of the Committee on Science, Space, and Technology”Map →
PersonBill Foster“Chairman of the Subcommittee on Investigations and Oversight”Map →
PersonCaitlin Rivers“Witness, Senior Scholar at Johns Hopkins Center for Health Security”Map →
PersonStephen Streiffer“Witness, Deputy Laboratory Director at Argonne National Laboratory”Map →
PersonJay Obernolte“Ranking Member of the Subcommittee”Map →
PersonNathan Grubaugh“Witness, Assistant Professor of Epidemiology”Map →
PersonSalim Abdool Karim“Witness, Director of CAPRISA”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance40
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz5
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record